We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Boston Scientific Corporation | NYSE:BSX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.175 | 0.24% | 74.625 | 74.745 | 74.175 | 74.60 | 3,060,385 | 20:34:01 |
UNITED STATES
|
||||
SECURITIES AND EXCHANGE COMMISSION
|
||||
Washington, D.C. 20549
|
||||
|
|
|
|
|
|
|
|
|
|
FORM 11-K
|
||||
|
||||
FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE,
|
||||
SAVINGS AND SIMILAR PLANS PURSUANT TO
|
||||
SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One):
|
|
|
|
|
|
|
|||
þ
|
ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|||
|
For the fiscal year ended December 31, 2015
|
|||
|
OR
|
|||
o
|
TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|||
|
For the transition period from
to
|
Commission file number: 1-11083
|
|
|
|||
|
|
|
|
|
|
|
A.
|
Full title of the plan and the address of the plan, if different from that of the issuer named below:
|
|||
|
|
|
Boston Scientific Corporation
|
|
|
|
|
|
401(k) Retirement Savings Plan
|
|
|
|
|
|
|
|
|
|
B.
|
Name of issuer of the securities held pursuant to the plan and the address of its principal executive
|
|||
|
|
office:
|
|
|
|
|
|
|
Boston Scientific Corporation
|
|
|
|
|
|
300 Boston Scientific Way
|
|
|
|
|
|
Marlborough, MA 01752
|
|
Audited Financial Statements
|
||||
and Supplemental Schedule
|
||||
|
||||
Boston Scientific Corporation
|
||||
401(k) Retirement Savings Plan
|
||||
|
||||
|
||||
As of December 31, 2015 and 2014 and for the Year Ended December 31, 2015
|
|
December 31,
|
||||||
|
2015
|
|
2014
|
||||
Assets
|
|
|
|
||||
Investments, at fair value
|
$
|
2,578,565,150
|
|
|
$
|
2,483,782,136
|
|
Receivables:
|
|
|
|
||||
Participant contributions
|
2,670,981
|
|
|
5,505
|
|
||
Employer contributions
|
1,986,384
|
|
|
7,516
|
|
||
Notes receivable from participants
|
26,317,681
|
|
|
27,409,075
|
|
||
Total receivables
|
30,975,046
|
|
|
27,422,096
|
|
||
|
|
|
|
||||
Net assets available for benefits
|
$
|
2,609,540,196
|
|
|
$
|
2,511,204,232
|
|
|
|
|
|
Additions:
|
|
||
Investment income:
|
|
||
Interest and dividends
|
$
|
78,207,111
|
|
Net depreciation in fair value of investments
|
(11,015,586
|
)
|
|
|
67,191,525
|
|
|
|
|
||
Interest income on notes receivable from participants
|
1,107,401
|
|
|
|
|
||
Contributions:
|
|
||
Participants
|
103,516,248
|
|
|
Employer
|
70,094,902
|
|
|
Participant rollovers
|
22,899,181
|
|
|
|
196,510,331
|
|
|
|
|
||
Total additions
|
264,809,257
|
|
|
|
|
||
Deductions:
|
|
||
Benefit payments
|
166,052,092
|
|
|
Administrative expenses
|
421,201
|
|
|
Total deductions
|
166,473,293
|
|
|
|
|
||
Net increase
|
98,335,964
|
|
|
|
|
||
Net assets available for benefits:
|
|
||
Beginning of year
|
2,511,204,232
|
|
|
End of year
|
$
|
2,609,540,196
|
|
|
December 31,
|
|||||
|
2015
|
2014
|
||||
Common stock:
|
|
|
||||
Boston Scientific Corporation Common Stock Fund
|
$
|
228,859,112
|
|
$
|
181,108,715
|
|
Mutual funds:
|
|
|
||||
Vanguard Institutional Index Fund Plus Shares
|
363,621,741
|
|
361,033,679
|
|
||
Vanguard Growth Index Fund Inst
|
259,007,400
|
|
251,256,942
|
|
||
Vanguard International Growth Fund
|
208,023,672
|
|
205,471,550
|
|
||
Vanguard Wellington Fund Admiral Shares
|
184,377,841
|
|
187,546,482
|
|
||
T. Rowe Price Small-Cap Stock Fund
|
168,333,973
|
|
181,454,272
|
|
||
Vanguard Windsor II Fund Investor Shares
|
153,947,815
|
|
168,835,019
|
|
||
Vanguard Total Bond Market Index Fund: Institutional Shares
|
144,395,412
|
|
133,189,521
|
|
||
Vanguard Mid-Cap Growth Fund
|
130,983,609
|
|
127,704,205
|
|
||
Stable Value Fund:
|
|
|
||||
Vanguard Retirement Savings Trust III
|
245,926,958
|
|
244,197,156
|
|
|
Investments at Fair Value as of December 31, 2015
|
|
|||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
||||||||
Mutual funds
|
$
|
1,665,420,474
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1,665,420,474
|
|
|
Common stock
|
228,859,112
|
|
—
|
|
—
|
|
228,859,112
|
|
|
||||
|
$
|
1,894,279,586
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1,894,279,586
|
|
|
Common/collective trust funds measured at net asset value:
|
|
|
|
|
|
||||||||
Common Collective Trusts
|
|
|
|
438,358,606
|
|
†
|
|||||||
Stable Value Fund
|
|
|
|
245,926,958
|
|
††
|
|||||||
Total investments at fair value
|
|
|
|
$
|
2,578,565,150
|
|
|
|
Investments at Fair Value as of December 31, 2014
|
|
|||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
||||||||
Mutual funds
|
$
|
1,673,200,176
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1,673,200,176
|
|
|
Common stock
|
184,444,285
|
|
—
|
|
—
|
|
184,444,285
|
|
|
||||
|
$
|
1,857,644,461
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1,857,644,461
|
|
|
Common/collective trust funds measured at net asset value:
|
|
|
|
|
|
||||||||
Common Collective Trusts
|
|
|
|
381,940,519
|
|
†
|
|||||||
Stable Value Fund
|
|
|
|
244,197,156
|
|
††
|
|||||||
Total investments at fair value
|
|
|
|
$
|
2,483,782,136
|
|
|
†
|
This category includes the Target Retirement trusts, which are investments in highly diversified funds designed to remain appropriate for investors in terms of risk throughout a variety of life circumstances. These common/collective trust funds share the common goal of first growing and then later preserving principal and contain a mix of common stocks, bonds, and cash. There are currently no redemption restrictions on these investments.
|
|
December 31,
|
||||||
|
2015
|
|
2014
|
||||
Net assets available for benefits per the financial statements
|
$
|
2,609,540,196
|
|
|
$
|
2,511,204,232
|
|
Adjustments from contract value to fair value for fully
|
|
|
|
||||
benefit-responsive investment contracts
|
—
|
|
|
7,496,169
|
|
||
Deemed distributions
|
(239,744
|
)
|
|
(79,968
|
)
|
||
Net assets available for benefits per the Form 5500
|
$
|
2,609,300,452
|
|
|
$
|
2,518,620,433
|
|
|
Year Ended
|
||
|
December 31,
|
||
|
2015
|
||
Net increase per the financial statements
|
$
|
98,335,964
|
|
Adjustments from contract value to fair value for fully
|
|
||
benefit-responsive investment contracts
|
(7,496,169
|
)
|
|
Deemed distributions
|
(159,776
|
)
|
|
Net income per the Form 5500
|
$
|
90,680,019
|
|
Identity of Issue
|
Description
|
|
Shares or Units
|
|
|
Current Value
|
|
|
*Vanguard Group:
|
|
|
|
|
|
|||
Institutional Index Fund Plus
|
Mutual Fund
|
|
1,948,356
|
|
|
$
|
363,621,741
|
|
Growth Index Fund Inst
|
Mutual Fund
|
|
4,729,001
|
|
|
259,007,400
|
|
|
International Growth Fund
|
Mutual Fund
|
|
9,858,942
|
|
|
208,023,672
|
|
|
Wellington Fund Admiral Shares
|
Mutual Fund
|
|
2,901,760
|
|
|
184,377,841
|
|
|
Windsor II Fund Investor Shares
|
Mutual Fund
|
|
4,595,457
|
|
|
153,947,815
|
|
|
Total Bond Market Index Fund Institutional
|
Mutual Fund
|
|
13,570,997
|
|
|
144,395,412
|
|
|
Mid-Cap Growth Fund
|
Mutual Fund
|
|
5,834,459
|
|
|
130,983,609
|
|
|
Target Retirement 2035 Trust II
|
Common Collective Trust
|
|
1,669,831
|
|
|
70,967,803
|
|
|
Target Retirement 2040 Trust II
|
Common Collective Trust
|
|
1,495,316
|
|
|
64,433,150
|
|
|
Target Retirement 2030 Trust II
|
Common Collective Trust
|
|
1,451,277
|
|
|
61,476,091
|
|
|
Target Retirement 2045 Trust II
|
Common Collective Trust
|
|
1,365,642
|
|
|
58,654,331
|
|
|
Target Retirement 2025 Trust II
|
Common Collective Trust
|
|
1,289,311
|
|
|
55,143,827
|
|
|
Target Retirement 2020 Trust II
|
Common Collective Trust
|
|
928,084
|
|
|
40,288,120
|
|
|
Target Retirement 2050 Trust II
|
Common Collective Trust
|
|
863,087
|
|
|
37,276,734
|
|
|
Target Retirement 2015 Trust II
|
Common Collective Trust
|
|
382,957
|
|
|
16,582,030
|
|
|
Target Retirement Income Trust II
|
Common Collective Trust
|
|
332,980
|
|
|
14,934,166
|
|
|
Target Retirement 2055 Trust II
|
Common Collective Trust
|
|
220,293
|
|
|
11,600,604
|
|
|
Target Retirement 2010 Trust II
|
Common Collective Trust
|
|
101,307
|
|
|
4,365,334
|
|
|
Target Retirement 2060 Trust II
|
Common Collective Trust
|
|
95,384
|
|
|
2,636,404
|
|
|
T. Rowe Price Small-Cap Stock Fund
|
Mutual Fund
|
|
4,359,854
|
|
|
168,333,973
|
|
|
Harbor International Fund Institutional
|
Mutual Fund
|
|
550,727
|
|
|
32,729,696
|
|
|
Artisan Mid Cap Value Fund Institutional
|
Mutual Fund
|
|
1,068,340
|
|
|
19,999,327
|
|
|
*Stable Value Fund:
|
|
|
|
|
|
|||
Vanguard Retirement Savings Trust III
|
Common Collective Trust
|
|
245,926,958
|
|
|
245,926,958
|
|
|
*Boston Scientific Corporation Common Stock Fund
|
Common Stock
|
|
12,411,015
|
|
|
228,859,112
|
|
|
*Notes receivable from Participants, interest rates 4.25% - 9.25%
|
|
|
|
|
26,317,681
|
|
||
|
|
|
|
|
$
|
2,604,882,831
|
|
|
|
|
|
|
Boston Scientific Corporation
|
||||||
|
|
|
|
|
401(k) Retirement Savings Plan
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Date:
|
June 28, 2016
|
|
|
|
By:
|
/s/ Daniel Bird
|
|||||
|
|
|
|
|
|
Daniel Bird
|
|||||
|
|
|
|
|
|
Vice President, Global Total Rewards and HR Operations
|
|||||
|
|
|
|
|
|
Member, Employee Benefits Committee
|
Exhibit Number
|
Description
|
|
|
|
|
|
|
|
|
23
|
Consent of Independent Registered Public Accounting Firm
|
1 Year Boston Scientific Chart |
1 Month Boston Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions